---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295265186.md"
description: "Starling Oncology shares are trading higher after the company reported a year-over-year decrease in Q2 loss per share and increase in sales results."
datetime: "2026-08-07T17:53:20.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295265186.md)
  - [en](https://longbridge.com/en/news/295265186.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295265186.md)
---

# 

Starling Oncology shares are trading higher after the company reported a year-over-year decrease in Q2 loss per share and increase in sales results.

### Related Stocks

- [STLN.US](https://longbridge.com/en/quote/STLN.US.md)

## Related News & Research

- [Oncology Institute Q2 FY26 net loss narrows 42.4% to $9.79 million; revenue rises 34.6% to $161.28 million](https://longbridge.com/en/news/295148886.md)
- [Starling Oncology lifts FY 2026 revenue outlook to $650-$670 million](https://longbridge.com/en/news/295149044.md)